VERTEX PHARMACEUTICALS INC (VRTX) Stock Institutional Owners


VERTEX PHARMACEUTICALS INC (VRTX) is held by 6 institutional investors with a total value of $914.20M. This comprehensive analysis highlights the top institutional holders led by Parnassus Endeavor Fund, Renaissance Technologies LLC, Tweedy, Browne Co All Funds (US), and others, who collectively account for nearly 99% of the total institutional ownership.Parnassus Endeavor Fund remains the largest institutional holder with a position worth $645.59M. Explore insights into ownership patterns, position sizes, and portfolio allocations to understand institutional investment strategies and market sentiment.

Explore more:

NameInvestor/ManagerPortfolio %QuantityReported Balance
Parnassus Endeavor FundParnassus Investments1.49%1,648,433$645,592,300
Renaissance Technologies LLCJim Simons0.36%505,048$228,968,561
Tweedy, Browne Co All Funds (US)B. Tweedy, Ch. Browne1.43%39,148$17,748,137
ARK InvestCathie Wood0.06%25,665$10,051,390
Torray FundRobert Torray0.86%16,255$6,366,108
Sequoia Financial Advisors0.03%13,980$5,475,119

Frequently asked questions about VRTX

  • Who owns the most VRTX stock?

    The largest holders of VRTX are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for VERTEX PHARMACEUTICALS INC (VRTX).

  • Is VRTX widely held by superinvestors?

    Many widely followed stocks like VRTX appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly VRTX is represented among the institutional managers we track.